Precision Medicine Diagnostics
News and analysis on diagnostic technologies and applications for precision medicine.
Voyager Therapeutics Exploring Alternate Payload in SOD1-ALS Gene Therapy Program
New three-month data from a study of nonhuman primates underpins the biotech firm's decision to amend the small interfering RNA program.
Maze Therapeutics Doses First Patient in Phase II APOL1 Inhibitor Kidney Disease Trial
Within the open-label basket trial, patients with two copies of one of two high-risk APOL1 gene variants will receive MZE829.
FDA Clears Aro Biotherapeutics' siRNA Drug IND for Late-Onset Pompe Disease
The company has already kicked off an open-label Phase I trial of ABX1100 in Canada following positive results from a study of healthy volunteers.
Flatiron Health, Exact Sciences Partner on Study of Molecular Residual Disease Test
The collaborators have enrolled their first patient in a prospective clinical study testing a tumor-informed assay for monitoring recurrence across multiple cancers.
University of Helsinki Spinout Developing Blood Test to Tailor Treatment For High Cholesterol
Premium
Moncyte Health's test evaluates biological differences in how cholesterol is transported and processed in cells, which can influence drug response.